Osteocardiology: Defining the Go/No-Go Time Point for Therapy

Area of Science:

• Cardiovascular Medicine
• Atherosclerosis Research
• Osteocardiology

Background:

• Epidemiological studies show shared risk factors for coronary artery calcification (CAC) and calcific aortic valve disease (CAVD), including male gender, smoking, hypertension, and high cholesterol.
• Traditional cardiovascular risk factors initiate atherosclerosis, which can progress to bone formation in the heart, leading to clinical CAC and CAVD.

Purpose of the Study:

• To review the development of bone formation in the heart, termed osteocardiology.
• To define the critical therapeutic intervention window, or "go/no-go" time point, between subclinical atherosclerosis and severe clinical calcification.

Main Methods:

• Review of experimental and clinical studies on cardiovascular calcification.
• Analysis of the cellular mechanisms underlying atherosclerosis progression to calcification.
• Identification of the transition point from subclinical to clinical calcification.

Main Results:

• Atherosclerosis progression involves cellular mechanisms that lead to bone formation in the heart.
• CAC and CAVD share common initiating risk factors and pathological pathways.
• A distinct time point exists between subclinical atherosclerosis and irreversible calcification.

Conclusions:

• Understanding osteocardiology is crucial for timing interventions against cardiovascular calcification.
• Defining the "go/no-go" point allows for targeted therapy to slow or halt the progression of heart bone formation.
• Early intervention based on identifying this critical time point may prevent severe clinical manifestations of CAC and CAVD.